Medtech Market Intelligence

To succeed in medtech, you need to have your finger on the pulse – but accurate, reliable information is not always easy to find. We can help you get what you need.

Fast growth in the medical technology market is driven by innovation, demographic shifts, cost-efficient development and increased M&A activity. Success in this arena depends on your ability to bring cutting-edge solutions to the fore quickly, and having accurate intelligence is crucial for a sound development strategy.

How we help

Our medtech market intelligence will keep you up-to-date with important events and help you anticipate future technology needs – so you can evaluate new market opportunities and make confident business decisions.

Find comprehensive and accurate information on devices/diagnostics that compete in your markets
Stay abreast of important current events in our space that will affect your business
Rapidly find information on opportunities or targets within the medtech arena
Stay up to date with new trends and innovation in order to evaluate opportunities as they arise

In Vivo

Bayer’s US Playbook: The Smart Way To Top-Line Growth

By William Looney 14 Nov 2022

The hotly contested US market is central to Bayer’s aspirations to become a global innovation player in pharmaceuticals, especially in key growth segments like oncology. A little more than one year in, Bayer Pharmaceuticals Americas President Dr. Carsten Brunn reflects on his unit’s progress.

Medtech Insight

Inside Toyota's 'Cult' Car-Makers Quality VP Tells Device-Makers How To Adopt 4-Pronged Quality Strategy

By Shawn M. Schmitt 14 Nov 2022

Toyota Motor North America's Kristen Tabar told a roomful of medical device quality and regulatory professionals at a Case for Quality forum that they can infuse quality concepts into every nook and cranny of their firms by adopting the car-maker's quality strategy of reflection, education, celebration and planning. "I don’t want to make it sound like it’s sort of cult-y, but it’s kind of cult-y," Tabar quipped.

In Vivo

Critical Insights into Market Access

14 Nov 2022

Your key to refining your market access strategy with essential patient market access mini-mag and infographic from the experts at In Vivo.

In Vivo

From US To EU: Young Biotechs Going It Alone

By Jo Shorthouse 14 Nov 2022

Europe’s patchwork of reimbursement agencies make it a daunting place for a small US biotech to do business. Traditionally large pharma partners or CMSOs have provided an experienced hand to hold, but as a new wave of gene therapies and orphan drugs get the EMA green light, smaller drug developers are applying innovation to commercialization and choosing to go solo.

Biomedtracker, Meddevicetracker

Q2 2022 Outlook Report

23 May 2022

In this report, we cover catalysts from 31 drugs, devices, diagnostics, and deals expected to occur in the second quarter of 2022.

In Vivo

Outlook 2022: What Next for Pharma After a Year of Innovation and Growth?

02 Mar 2022

Look ahead with our Pharma Outlook 2022 Extract as we discuss what's coming up in the biopharma space.

Biomedtracker, Meddevicetracker

Don’t miss your free extract of Early 2022 Outlook Report

08 Feb 2022

In pharma’s fast paced and continually evolving world, accurately anticipating the impact of events on the horizon is critical to your success.

Medtech Insight

FDA, Industry To Miss MDUFA V Congressional Deadline; Insiders At Odds Over Future Of Deal

By Ferdous Al-Faruque 14 Jan 2022

The US agency and the medtech industry still have significant disagreements, which means they will miss a 15 January deadline to send the MDUFA V user-fee deal to Congress. Insiders disagree, however, on how severe those disagreements are and when a deal can be reached.

Medtech Insight

Execs On The Move: Acarix And Paige Appoint New CEOs

14 Jan 2022

MT2107_Executives_on_the_move_2C3P31H_1200

Paige, an AI-for-digital-pathology company, and Acarix AB, developers of an acoustic cardiac diagnostic both have new chiefs.

Medtech Insight

JPM 2022: Abiomed, Penumbra, Renalityx

By Reed Miller 13 Jan 2022

The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022 as they continue to cope with the impact of the Omicron surge. Here are some of the highlights from the presentations on the fourth day of the meeting.

In Vivo

Five (Non-COVID) Clinical Trial Hits Of 2021

By Alex Shimmings 05 Jan 2022

2021 may have been dominated by the continuing coronavirus pandemic, but that did not stop industry’s more bread and butter R&D activities. Here, In Vivo takes a look at five of the more notable clinical trial hits of the year.

In Vivo

Innovation Trends Point To More Positives For Health Care Investors

By Ashley Yeo 28 Dec 2021

At the end of a turbulent year for health care, COVID-19 is still dominating the thoughts of stakeholders, but CMS patent attorneys Jane Hollywood and Rob Stephen are encouraged by the innovation and investment trends that are making it an exciting time to be in the thick of the action.

Medtech Insight

US FDA-Sponsored Cybersecurity Threat Modeling Playbook Tries To Make It Simple

By Ferdous Al-Faruque 30 Nov 2021

The MITRE corporation and MDIC have produced a manual on how to use cybersecurity threat modeling to make safer medical devices. The document asks four basic questions and provides helpful examples.

Medtech Insight

Exec Chat: CMR Surgical Prepares For Intensifying Competition In RAS

By Barnaby Pickering 30 Nov 2021

In an interview with Medtech Insight, Per Vegard Nerserth, CEO of CMR Surgical, discusses how the company adapted to the pandemic, its future plans, and how the competition for market dominance is shaping up.

In Vivo

How Will Pfizer Leverage External Innovation After BioNTech Jackpot?

By Lucie Ellis-Taitt 22 Nov 2021

Uwe Schoenbeck, CSO of external science and innovation at Pfizer, knows the company set itself a high bar during the COVID-19 pandemic after rapidly bringing a breakthrough vaccine to market. While the circumstances for the development of Comirnaty were truly unique, Pfizer does not expect to rest on its laurels when it comes to innovative R&D.

Medtech Market Intelligence

Accurate expert analysis for a fragmented market

Relevant products

Below are the Product List

Medtech Insight: global medical technology news & analysis

Meddevicetracker: medical device intelligence and forecasts

In Vivo: strategic insights for life sciences decision-makers

Pharma Intelligence latest insights

Latest headlines

Next steps

This is Contactus Section

Request a live demo

Speak to Sales

Client Services

Pharma Report Store